Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balram Gautam

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|January 11, 2025
CAR-T cell therapy in developing countries: how long should we wait?Sanjivan Gautam, Balram Gautam, Ramila Shilpakar, et al.
Journal of Nepal Health Research Council|February 10, 2022
KRAS Oncogene Mutations in Colorectal Cancer Patients in a Nepalese Tertiary Care HospitalBhupendra Kumar Basnet, Balram Gautam, Kamal Ranabhat, et al.
Journal of Nepal Health Research Council|January 10, 2024
Outcome of Epidermal Growth Factor Receptor Mutated and Non Mutated Adenocarcinoma Lung to Standard TherapySoniya Dulal, Akshat Mishra, Aarati Shah, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|January 11, 2025
CAR-T cell therapy in developing countries: how long should we wait?Sanjivan Gautam, Balram Gautam, Ramila Shilpakar, et al.
Journal of Nepal Health Research Council|February 10, 2022
KRAS Oncogene Mutations in Colorectal Cancer Patients in a Nepalese Tertiary Care HospitalBhupendra Kumar Basnet, Balram Gautam, Kamal Ranabhat, et al.
Journal of Nepal Health Research Council|January 10, 2024
Outcome of Epidermal Growth Factor Receptor Mutated and Non Mutated Adenocarcinoma Lung to Standard TherapySoniya Dulal, Akshat Mishra, Aarati Shah, et al.
Pageof 1